RA Capital Management’s Cogent Biosciences COGT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,416,147	Closed	-$62.6M	–	65
2023 Q3	$62.6M	Hold	6,416,147	–	–	1.23%	23
2023 Q2	$76M	Buy	6,416,147 +416,666	+7%	+$4.78M	1.43%	19
2023 Q1	$64.7M	Hold	5,999,481	–	–	1.47%	23
2022 Q4	$69.4M	Buy	5,999,481 +1,986,028	+49%	+$24.6M	1.41%	23
2022 Q3	$59.9M	Buy	+4,013,453	New	+$55M	1.28%	27
2022 Q1	–	Sell	-1,025,641	Closed	-$8.8M	–	99
2021 Q4	$8.8M	Hold	1,025,641	–	–	0.16%	86
2021 Q3	$8.63M	Hold	1,025,641	–	–	0.12%	83
2021 Q2	$8.32M	Hold	1,025,641	–	–	0.13%	79
2021 Q1	$9.01M	Hold	1,025,641	–	–	0.14%	73
2020 Q4	$11.5M	Buy	+1,025,641	New	+$11.3M	0.16%	67